Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for intraoperative sedation during knee arthroscopy under spinal anesthesia
ChiCTR2100048306Phase 4Not yet recruiting
- Sponsor
- Central Hospital of Enshi Tujia and Miao Autonomous Prefecture
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in procedural sedation and analgesia (PSA) (2 arms), sponsored by Central Hospital of Enshi Tujia and Miao Autonomous Prefecture. Primary endpoints: Incidence of hypotension and Incidence of postoperative dizziness, nausea and vomiting. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2100048306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048306.